Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4344615 | 0.89 | PTPN1 (0.36) | PTPN1CTSSPPARATLR2 | |
| SCHEMBL13613768 | 0.85 | PTPN1 (0.36) | PTPN1CTSS | |
| SCHEMBL4356049 | 0.76 | CTSS (0.39) | PTPN1CTSSPPARA | |
| SCHEMBL4356052 | 0.76 | CTSS (0.39) | PTPN1CTSSPPARA | |
| SCHEMBL12880712 | 0.72 | KLK7 (0.40) | TLR2 | |
| SCHEMBL30844631 | 0.69 | PPARA (0.55) | CTSSPPARA | |
| SCHEMBL28430224 | 0.69 | PPARA (0.55) | CTSSPPARA | |
| SCHEMBL28430225 | 0.69 | PPARA (0.55) | CTSSPPARA | |
| SCHEMBL2583829 | 0.69 | PPARA (0.55) | CTSSPPARA | |
| SCHEMBL30416417 | 0.69 | PPARA (0.55) | CTSSPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | IAPP, GLP1R, VIP | PTPN1 2158/4885PSMB5 1726/4885CTSS 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.